Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
902.15
10.60 (1.19%) Cadila Healthcare informs about press release
Date: 27-01-2022Cadila Healthcare has informed that it enclosed the Newspaper Publication of Notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati Editions, both on January 26, 2022.
The above information is a part of company’s filings submitted to BSE.